These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9350245)

  • 1. [Histopathological effect of neoadjuvant chemohormonal therapy for prostatic cancer].
    Maruoka M; Hamano K; Nishikawa Y; Nagayama T
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1975-80. PubMed ID: 9350245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical neoadjuvant chemo-hormonal therapy for advanced prostatic carcinoma].
    Maruoka M; Nishikawa Y; Miyauchi T; Nagayama T
    Hinyokika Kiyo; 1994 Jul; 40(7):581-6. PubMed ID: 8085518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
    Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complete remission of prostate cancer after LH-RH agonist neoadjuvant therapy: a case report].
    Furuse H; Ishikawa A; Masuda H; Ushiyama T; Suzuki K; Fujita K
    Hinyokika Kiyo; 1995 Jun; 41(6):485-8. PubMed ID: 7645458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
    Ushiyama T; Ihara H; Kurita Y; Kageyama S; Ueda D; Mugiya S; Yamaguchi Y; Nakano M; Suzuki K; Kawabe K
    Hinyokika Kiyo; 1993 Dec; 39(12):1139-44. PubMed ID: 8285162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Total androgen blockade for prostate cancer].
    Kagebayashi Y; Ozono S; Takashima K; Yoshikawa M; Hayashi Y; Kaneko Y; Maruyama Y; Hirao Y; Okajima E
    Hinyokika Kiyo; 1997 Mar; 43(3):197-201. PubMed ID: 9127754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on prevention of flare-up phenomenon following initial LH-RH analogue administration: combination therapy with diethylstilbestrol].
    Takeuchi S; Yoshida K; Tosaka A; Kobayashi N; Higashi Y; Negishi T
    Hinyokika Kiyo; 1995 Mar; 41(3):191-6. PubMed ID: 7741071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of clinically localized prostatic cancer--endocrine therapy].
    Hirano A
    Hinyokika Kiyo; 1996 Oct; 42(10):829-32. PubMed ID: 8951483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inference network-based analyses of the histopathological effects of androgen deprivation on prostate cancer.
    Montironi R; Santinelli A; Pomante R; Hamilton PW; Thompson D; Bartels PH
    J Pathol; 1999 Mar; 187(4):462-8. PubMed ID: 10398107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total cystoprostatectomy in the treatment of locally advanced prostate carcinoma.
    Sato K; Tsuchiya N; Habuchi T; Satoh S; Shimoda N; Kato T
    Aktuelle Urol; 2003 Jul; 34(4):259-61. PubMed ID: 14566679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of neuroendocrine differentiation with neoadjuvant hormone therapy effects in prostatic cancer.
    Tokunaga M; Yasuda M; Osamura RY; Itoh J; Mukai M; Shima M; Usui Y; Masuda A; Miyakita H; Terachi T
    Oncol Rep; 2005 Jun; 13(6):1081-7. PubMed ID: 15870925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.
    Amato RJ; Hernandez-McClain J; Henary H
    Am J Clin Oncol; 2008 Dec; 31(6):532-8. PubMed ID: 19060583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy.
    Shepard DR; Dreicer R; Garcia J; Elson P; Magi-Galluzzi C; Raghavan D; Stephenson AJ; Klein EA
    J Urol; 2009 Apr; 181(4):1672-7; discussion 1677. PubMed ID: 19230915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant endocrine therapy prior to nerve-sparing radical prostatectomy in patients with stage T2 prostatic cancer].
    Ueda T; Nakatsu H; Isaka S; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1995 Jul; 86(7):1266-71. PubMed ID: 7637243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.
    Montgomery RB; Nelson PS; Lin D; Ryan CW; Garzotto M; Beer TM
    Cancer; 2007 Sep; 110(5):996-1002. PubMed ID: 17639587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer].
    Tsukamoto S; Akaza H
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer.
    Azuma H; Sakamoto T; Kiyama S; Ubai T; Kotake Y; Inamoto T; Takahara K; Nishimura Y; Segawa N; Katsuoka Y
    Am J Clin Oncol; 2008 Apr; 31(2):188-94. PubMed ID: 18391605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of poor prognostic patients with advanced prostatic carcinoma with the association of diethylstilbestrol and cyclophosphamide.
    Germá Lluch JR; Marcuello Gaspar E; de Andrés Basauri L; López Pousa A; López López JJ
    Rev Esp Oncol; 1982; 29(2):317-24. PubMed ID: 7188232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostate.
    Amato RJ; Teh BS; Henary H; Khan M; Saxena S
    Urol Oncol; 2009; 27(2):165-9. PubMed ID: 18367115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of Bcl-2 expression favors response to the short-term administration of diethylstilbestrol diphosphate in prostate Cancer.
    Nagaoka A; Kubota Y; Kurosu S; Nakada T; Bilim V; Tomita Y; Motoyama T
    Prostate; 2006 Dec; 66(16):1779-87. PubMed ID: 16998806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.